Secondary listing on the A2X Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis” or “the Company”) SECONDARY LISTING ON A2X The Board of Ascendis is pleased to announce that the ordinary shares of Ascendis have been approved for inclusion in the list of qualifying equity securities to be traded on A2X with effect from 29 May 2018 (the "A2X listing date"). Ascendis has a primary listing on the JSE and its issued ordinary share capital will be unaffected by its secondary listing on A2X. Ascendis ordinary shares will be available to be traded on both the JSE and A2X from the A2X listing date. A2X is a licensed stock exchange authorised to provide a secondary listing venue for companies and is regulated by the Financial Sector Conduct Authority in terms of the Financial Markets Act 19 of 2012. Johannesburg 22 May 2018 Sponsor: Questco Corporate Advisory (Pty) Ltd Date: 22/05/2018 09:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Email this JSE Sens Item to a Friend.